Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Associations Between Cancer-Related Financial Hardship, Pain, and Opioid Use

View through CrossRef
PURPOSE Cancer-related financial hardship, encompassing the high out-of-pocket treatment costs and associated distress, is associated with adverse treatment outcomes. However, its impact on clinical outcomes such as pain remains underexplored. METHODS This secondary, retrospective cohort study examined associations between financial hardship and pain among patients with cancer initiating systemic therapy. Patient-reported pain was captured weekly over the first 6 months of treatment via remote symptom monitoring. Financial hardship was assessed at treatment initiation via the FACIT-COST instrument. Opioid use was abstracted from electronic medical records. Generalized linear models estimated associations between pain and financial hardship using relative risks (RR), predicted probabilities, and corresponding 95% CIs. Associations between financial hardship and opioid use were similarly modeled, stratified by pain severity. RESULTS Of 331 patients (median age 60 years; 28% Black; 40% stage IV), 48% reported financial hardship. Moderate/severe pain was reported by 25% and 24% at 3 and 6 months after treatment initiation, respectively. In adjusted models, patients reporting financial hardship had a 37% higher risk of moderate/severe pain over 6 months compared with those reporting no/minimal financial hardship (RR, 1.37 [95% CI, 1.04 to 1.80]). During cancer treatment, patients reporting financial hardship had higher probabilities of opioid use than those reporting no/minimal financial hardship, both among those with moderate/severe (55% [95% CI, 40 to 77] v 44% [95% CI, 30 to 63]) and no/mild pain (40 [95% CI, 30 to 53] v 30% [95% CI, 21 to 42]). CONCLUSION Financial hardship is associated with increased risk of pain and greater opioid use during cancer treatment. Integrating financial screening into clinical workflows may identify high-risk patients and inform interventions, such as financial navigation and tailored pain management, to mitigate the clinical consequences of financial hardship.
Title: Associations Between Cancer-Related Financial Hardship, Pain, and Opioid Use
Description:
PURPOSE Cancer-related financial hardship, encompassing the high out-of-pocket treatment costs and associated distress, is associated with adverse treatment outcomes.
However, its impact on clinical outcomes such as pain remains underexplored.
METHODS This secondary, retrospective cohort study examined associations between financial hardship and pain among patients with cancer initiating systemic therapy.
Patient-reported pain was captured weekly over the first 6 months of treatment via remote symptom monitoring.
Financial hardship was assessed at treatment initiation via the FACIT-COST instrument.
Opioid use was abstracted from electronic medical records.
Generalized linear models estimated associations between pain and financial hardship using relative risks (RR), predicted probabilities, and corresponding 95% CIs.
Associations between financial hardship and opioid use were similarly modeled, stratified by pain severity.
RESULTS Of 331 patients (median age 60 years; 28% Black; 40% stage IV), 48% reported financial hardship.
Moderate/severe pain was reported by 25% and 24% at 3 and 6 months after treatment initiation, respectively.
In adjusted models, patients reporting financial hardship had a 37% higher risk of moderate/severe pain over 6 months compared with those reporting no/minimal financial hardship (RR, 1.
37 [95% CI, 1.
04 to 1.
80]).
During cancer treatment, patients reporting financial hardship had higher probabilities of opioid use than those reporting no/minimal financial hardship, both among those with moderate/severe (55% [95% CI, 40 to 77] v 44% [95% CI, 30 to 63]) and no/mild pain (40 [95% CI, 30 to 53] v 30% [95% CI, 21 to 42]).
CONCLUSION Financial hardship is associated with increased risk of pain and greater opioid use during cancer treatment.
Integrating financial screening into clinical workflows may identify high-risk patients and inform interventions, such as financial navigation and tailored pain management, to mitigate the clinical consequences of financial hardship.

Related Results

Woningcorporaties en Vastgoedontwikkeling
Woningcorporaties en Vastgoedontwikkeling
This summary highlights the findings of the PhD-thesis ‘Woningcorporaties en Vastgoedontwikkeling: Fit for Use’ (‘Housing associations and Real Estate Development: Fit for Use?’). ...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Abstract 4360: Opioid, non-opioid, and non-pharmacological pain management in patients with a history of cancer
Abstract 4360: Opioid, non-opioid, and non-pharmacological pain management in patients with a history of cancer
Abstract Background Pain is highly prevalent among individuals with cancer. Consequently, adequate and equitable pain management are hallmarks of quality cancer care...
Effectiveness of Perioperative Opioid Educational Initiatives: A Systematic Review and Meta-Analysis
Effectiveness of Perioperative Opioid Educational Initiatives: A Systematic Review and Meta-Analysis
BACKGROUND: Opioids are the most commonly prescribed analgesics in the United States. Current guidelines have proposed education initiatives to reduce the risk ...
Discharge opioid prescribing guideline among the urological surgery patient population
Discharge opioid prescribing guideline among the urological surgery patient population
Background: Among the urological surgery patient population, the conventional opioid prescribing practice is arbitrary, provider preferential, and is not data-driven. The current p...
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Objective: To compare naloxone doses and clinical outcomes after emergency opioid reversal in opioid-naïve and opioid-tolerant inpatients.Design: Cross-sectional, retrospective cha...

Back to Top